The Global Resource For Connecting Buyers and Sellers

Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2017 Sales Results and 2018 Program Milestones

SAN DIEGO, Jan. 7, 2018 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced an update on its business performance, including preliminary sales results for 2017 and key program initiatives for 2018.  Kevin Gorman, CEO of Neurocrine, will discuss these updates as part…